全文获取类型
收费全文 | 150473篇 |
免费 | 10517篇 |
国内免费 | 531篇 |
专业分类
耳鼻咽喉 | 1829篇 |
儿科学 | 3950篇 |
妇产科学 | 2665篇 |
基础医学 | 19734篇 |
口腔科学 | 2712篇 |
临床医学 | 15237篇 |
内科学 | 31484篇 |
皮肤病学 | 2210篇 |
神经病学 | 14426篇 |
特种医学 | 4856篇 |
外国民族医学 | 7篇 |
外科学 | 21603篇 |
综合类 | 2408篇 |
现状与发展 | 1篇 |
一般理论 | 208篇 |
预防医学 | 13473篇 |
眼科学 | 3758篇 |
药学 | 10876篇 |
2篇 | |
中国医学 | 208篇 |
肿瘤学 | 9874篇 |
出版年
2023年 | 681篇 |
2022年 | 1079篇 |
2021年 | 2638篇 |
2020年 | 1580篇 |
2019年 | 2584篇 |
2018年 | 2909篇 |
2017年 | 2243篇 |
2016年 | 2511篇 |
2015年 | 3049篇 |
2014年 | 4342篇 |
2013年 | 6671篇 |
2012年 | 9606篇 |
2011年 | 10241篇 |
2010年 | 5812篇 |
2009年 | 5478篇 |
2008年 | 9605篇 |
2007年 | 10256篇 |
2006年 | 10141篇 |
2005年 | 10436篇 |
2004年 | 9913篇 |
2003年 | 9530篇 |
2002年 | 9009篇 |
2001年 | 1401篇 |
2000年 | 1103篇 |
1999年 | 1470篇 |
1998年 | 2026篇 |
1997年 | 1694篇 |
1996年 | 1421篇 |
1995年 | 1387篇 |
1994年 | 1136篇 |
1993年 | 1165篇 |
1992年 | 897篇 |
1991年 | 824篇 |
1990年 | 771篇 |
1989年 | 716篇 |
1988年 | 675篇 |
1987年 | 634篇 |
1986年 | 623篇 |
1985年 | 750篇 |
1984年 | 930篇 |
1983年 | 930篇 |
1982年 | 1290篇 |
1981年 | 1172篇 |
1980年 | 1044篇 |
1979年 | 517篇 |
1978年 | 634篇 |
1977年 | 611篇 |
1976年 | 507篇 |
1975年 | 454篇 |
1974年 | 420篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
102.
103.
104.
105.
106.
107.
Sherry X Yang Richard M Simon Antoinette R Tan Diana Nguyen Sandra M Swain 《Clinical cancer research》2005,11(17):6226-6232
PURPOSE: To delineate gene expression patterns and profile changes in metastatic tumor biopsies at baseline and 1 month after treatment with the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor erlotinib in patients with metastatic breast cancer. EXPERIMENTAL DESIGN: Patients were treated with 150 mg of oral erlotinib daily. Gene expression profiles were measured with Affymetrix U133A GeneChip and immunohistochemistry was used to validate microarray findings. RESULTS: Estrogen receptor (ER) status by immunohistochemistry is nearly coincided with the two major expression clusters determined by expression of genes using unsupervised hierarchical clustering analysis. One of 10 patients had an EGFR-positive tumor detected by both microarray and immunohistochemistry. In this tumor, tissue inhibitor of metalloproteinases-3 and collagen type 1 alpha 2, which are the EGF-down-regulated growth repressors, were significantly increased by erlotinib. Gene changes in EGFR-negative tumors are those of G-protein-linked and cell surface receptor-linked signaling. Gene ontology comparison analysis pretreatment and posttreatment in EGFR-negative tumors revealed biological process categories that have more genes differentially expressed than expected by chance. Among 495 gene ontology categories, the significant differed gene ontology groups include G-protein-coupled receptor protein signaling (34 genes, P = 0.002) and cell surface receptor-linked signal transduction (74 genes, P = 0.007). CONCLUSIONS: ER status reflects the major difference in gene expression pattern in metastatic breast cancer. Erlotinib had effects on genes of EGFR signaling pathway in the EGFR-positive tumor and on gene ontology biological process categories or genes that have function in signal transduction in EGFR-negative tumors. 相似文献
108.
Jim Orford Lorna Templeton Asmita Patel Richard Velleman Alex Copello 《Drugs (Abingdon, England)》2007,14(2):117-135
Background: This is the second of two papers using qualitative methods from a study of an intervention for family members affected by close relatives' substance misuse problems.
Participants: 168 primary healthcare professionals (PHCPs: GPs, practice nurses and health visitors) working in general practices in two areas of England, and who took part in the study.
Data sources: Recruitment and post-session forms completed by PHCPs; telephone interviews with each PHCP 12 weeks after recruitment of a family member; interviews with PHCPs at the end of the study.
Results: At the end of the project PHCPs were overwhelmingly positive about the family member intervention and about primary care as the appropriate site. Difficulties were encountered, however, in identifying and engaging affected family members, who were often excluded on grounds of the complexity of their problems or the level of their distress. Shortage of PHCP time and other practice-related factors added to the difficulty. Active work by a PHCP was often necessary in order to make the link between presenting symptoms of physical or mental ill-health and the existence of a family substance misuse problem. When family members were identified and recruited, PHCPs were usually positive about what was achieved. Nearly all were in favour of an approach that combined giving a self-help manual with some follow-up contact with a family member as needed.
Conclusions: Taken in conjunction with statistical outcome findings of significant reductions in symptoms and changes in ways of coping, plus qualitative analysis of the views of family members, the present results encourage the view that a flexible form of this intervention should be developed for use in primary healthcare, and that further work should build on existing strengths and attempt to overcome weaknesses identified. 相似文献
Participants: 168 primary healthcare professionals (PHCPs: GPs, practice nurses and health visitors) working in general practices in two areas of England, and who took part in the study.
Data sources: Recruitment and post-session forms completed by PHCPs; telephone interviews with each PHCP 12 weeks after recruitment of a family member; interviews with PHCPs at the end of the study.
Results: At the end of the project PHCPs were overwhelmingly positive about the family member intervention and about primary care as the appropriate site. Difficulties were encountered, however, in identifying and engaging affected family members, who were often excluded on grounds of the complexity of their problems or the level of their distress. Shortage of PHCP time and other practice-related factors added to the difficulty. Active work by a PHCP was often necessary in order to make the link between presenting symptoms of physical or mental ill-health and the existence of a family substance misuse problem. When family members were identified and recruited, PHCPs were usually positive about what was achieved. Nearly all were in favour of an approach that combined giving a self-help manual with some follow-up contact with a family member as needed.
Conclusions: Taken in conjunction with statistical outcome findings of significant reductions in symptoms and changes in ways of coping, plus qualitative analysis of the views of family members, the present results encourage the view that a flexible form of this intervention should be developed for use in primary healthcare, and that further work should build on existing strengths and attempt to overcome weaknesses identified. 相似文献
109.
Christopher G. Acker Richard Flick Ron Shapiro Velma P. Scantlebury Mark L. Jordan Carlos Vivas Arthur Greenberg John P. Johnson 《American journal of transplantation》2002,2(1):57-61
Delayed graft function (DGF) in cadaver kidney transplants is a common problem and is often due to acute tubular necrosis (ATN). DGF in transplants may have a deleterious effect on long-term graft survival. Since thyroid hormone has been shown to hasten recovery from ATN in experimental models, we designed a trial to determine if a defined course of triiodothyronine (T3) would improve the short- or long-term outcome of patients with DGF in cadaveric transplants. A prospective, randomized, placebo controlled, double blind trial of T3 was carried out in patients with DGF in cadaveric renal transplants. End-points were percentage requiring dialysis, percentage recovering function, time to recovery and length of hospital stay. Long-term outcomes were percentage grafts functioning at 1 year and mean serum creatinine at 1 year. Forty-four patients were randomized to receive either T3 or placebo. Three patients were dropped from each group when early biopsies disclosed that DGF was due to rejection. The groups were well matched by age, cold ischemia time of the graft, and percentage reactivity to a random panel of antigens. Baseline thyroid function studies, including T3, reverse T3 (rT3), and thyroid stimulating hormone (TSH) levels, were similar between the two groups and typical of 'euthyroid-sick syndrome'. T3 had no effect on percentage requiring dialysis, time to recovery, percentage recovering function, or length of stay. At 1 year follow-up, graft function was similar in both groups and significantly lower than that seen in patients with good initial function. Thyroid hormone, given early in the course of DGF in cadaver kidney recipients, had no effect on the course of DGF. Long-term graft function is impaired in patients who experience post-transplant DGF compared to those who have good initial function. 相似文献
110.